Serial 99393404
Live / Allowed — Published for opposition (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 15 Sept 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99393404
- Mark type
- Design / logo
- Filed
- 15 Sept 2025
- Published for opposition
- 10 Mar 2026
- Attorney of record
- Carissa L. Weiss
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of neurologic, rare neurologic, neuropsychiatric, rare neuropsychiatric, metabolic, rare metabolic, genetic, rare genetic, psychologic, rare psychologic, psychiatric, and rare psychiatric diseases and disorders
- Class 016 — Paper goods and printed matter: Printed publications, namely, brochures, pamphlets, newsletters, written articles and guidebooks in the field of medical information and patient support
- Class 035 — Advertising and business services: Promoting awareness of patient support offerings for neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders; Promoting awareness of patient support offerings for pain associated with neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders; Business administration services in the field of healthcare, namely, business administration of reimbursement and medical benefit information for neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions and their treatment; Business administration services in the field of healthcare, namely, business administration of reimbursement and medical benefit information for treatment of pain associated with neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions; Business administrative services for medical referrals
- Class 036 — Insurance and financial services: Insurance claims administration; Providing counseling and consulting in the field of healthcare insurance benefits; Providing information about healthcare insurance plans; Providing health insurance information; Providing financial information in the field of medical benefits and reimbursements available for medical expenses related thereto; Providing financial information in the field of insurance benefits and coverage for health care providers and patients in the field of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders
- Class 041 — Education and entertainment services: Educational services, namely, conducting programs in the field of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders and treatment and patient support options for these conditions
- Class 042 — Scientific and technological services: Providing on-line non-downloadable software for administering medical benefits and enrolling in benefits patient support program services; Biomedical research services; Industrial research in the field of biotechnology; Scientific research; Scientific and technological services, namely, research and design in the field of biotechnology and biomedicine; Providing scientific research information in the field of biotechnology and biomedicine; Chemical, biochemical, biological and bacteriological research and analysis; Biological research and analysis; Testing of pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research and development; Pharmaceutical research in the field of medical testing, namely, in vitro and in vivo preclinical testing of potential drugs; Providing medical research information in the field of pharmaceuticals
- Class 044 — Medical, beauty and agricultural services: Consultancy in the field of the medical treatment of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions; Consultancy in the field of the medical diagnosis of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions; Medical information; Providing medical information via a website; Providing personalized healthcare and medical information in the nature of providing information about the therapeutic benefits of pharmaceutical products, medical information regarding disease management, and healthcare-related information to patients and healthcare professionals in the fields of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders; Providing medical information in the field of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders
Owner
- Acadia Pharmaceuticals Inc., San Diego, CA, US
- Acadia Pharmaceuticals Inc., San Diego, CA, US
Prosecution history
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 10 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
- 10 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
- 10 Feb 2026 — ASSIGNED TO EXAMINER
- 10 Feb 2026 — ASSIGNED TO EXAMINER
- 09 Feb 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 09 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 15 Sept 2025 — NEW APPLICATION ENTERED